↓ Skip to main content

Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model

Overview of attention for article published in Frontiers in oncology, November 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model
Published in
Frontiers in oncology, November 2022
DOI 10.3389/fonc.2022.911835
Pubmed ID
Authors

Kyrhatii Trikhirhisthit, Jiraporn Setakornnukul, Kullathorn Thephamongkhol

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 14%
Librarian 1 7%
Student > Bachelor 1 7%
Student > Doctoral Student 1 7%
Researcher 1 7%
Other 1 7%
Unknown 7 50%
Readers by discipline Count As %
Nursing and Health Professions 2 14%
Medicine and Dentistry 2 14%
Engineering 1 7%
Unknown 9 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2022.
All research outputs
#21,317,636
of 26,179,695 outputs
Outputs from Frontiers in oncology
#11,670
of 22,919 outputs
Outputs of similar age
#369,369
of 498,472 outputs
Outputs of similar age from Frontiers in oncology
#975
of 1,505 outputs
Altmetric has tracked 26,179,695 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,919 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 498,472 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,505 others from the same source and published within six weeks on either side of this one. This one is in the 7th percentile – i.e., 7% of its contemporaries scored the same or lower than it.